Patent: 10,099,996
✉ Email this page to a colleague
Summary for Patent: 10,099,996
Title: | Compositions and methods of use of phorbol esters in the treatment of neoplasms |
Abstract: | Methods and compositions containing a phorbol ester or a derivative of a phorbol ester are provided for the treatment of chronic and acute conditions. Such conditions may be caused by disease, be symptoms, treatments, or sequelae of disease. The phorbol esters described are particularly useful in the treatment of neoplastic diseases and/or managing the side effects of chemotherapeutic and radiotherapeutic treatments of neoplastic diseases. |
Inventor(s): | Han; Zheng Tao (Eugene, OR), Chen; Hung-Fong (Taipei, TW) |
Assignee: | Biosuccess Biotech Co. Ltd. (Santa Clara, CA) |
Application Number: | 14/025,206 |
Patent Claims: | see list of patent claims |
Details for Patent 10,099,996
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2032-01-18 |
Clinigen, Inc. | PROLEUKIN | aldesleukin | For Injection | 103293 | 05/05/1992 | ⤷ Try a Trial | 2032-01-18 |
Wyeth Pharmaceuticals Llc | MYLOTARG | gemtuzumab ozogamicin | For Injection | 761060 | 09/01/2017 | ⤷ Try a Trial | 2032-01-18 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |